The role of LDLR in balancing plasma cholesterol levels was first reported by Brown and Goldstein in 1986, when they studied the physiological mechanism of a genetic disease called familial hypercholesterolemia (FH) [51]. This evidence concerns the gene LDLR and familial hypercholesterolemia.